Home HBM US

HBM US

In operation
-
Biological New Drug Developer
Basic
Enterprise Profile

Basic Information

HBM US is a wholly-owned subsidiary of Harbour BioMed. HBM US is a biopharmaceutical company focused on the research, development, and commercialization of innovative drugs, creating novel biologics with significant clinical value for the treatment of oncology and immunological diseases.
Harbour BioMed US, Inc.
Cambridge,Massachusetts,United States of America
unclear
--
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Application Scenarios
Innovative Drugs